OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs
Wallace Chan, Keith M. Olson, Jesse W. Wotring, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Mutations in SARS-CoV-2 structural proteins: a global analysis
Mohammad Abavisani, Karim Rahimian, Bahar Mahdavi, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 59

Domperidone inhibits dengue virus infection by targeting the viral envelope protein and nonstructural protein 1
Nuttapong Kaewjiw, Thanawat Thaingtamtanha, Damini Mehra, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics
Ahmed O. Mohammed, Mazin I. Abo-Idrees, Alaa A. Makki, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1553-1567
Open Access | Times Cited: 13

Exploring the Fatty Acid Binding Pocket in the SARS-CoV-2 Spike Protein – Confirmed and Potential Ligands
Luís Queirós-Reis, João R. Mesquita, Andrea Brancale, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 23, pp. 7282-7298
Open Access | Times Cited: 7

The Microalgal Diatoxanthin Inflects the Cytokine Storm in SARS-CoV-2 Stimulated ACE2 Overexpressing Lung Cells
Clementina Sansone, Luigi Pistelli, Angelo Del Mondo, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1515-1515
Open Access | Times Cited: 10

In silico screening of some compounds derived from the desert medicinal plant Rhazya stricta for the potential treatment of COVID-19
Nabih A. Baeshen, Abdulaziz Albeshri, Naseebh N. Baeshen, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8

Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design
S. Anusuya, V. Anbazhagan, M. Michael Gromiha
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 29, pp. 2396-2409
Closed Access | Times Cited: 8

Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host
Shivangi Agrawal, Ekta Pathak, Rajeev Mishra, et al.
Computers in Biology and Medicine (2022) Vol. 149, pp. 106049-106049
Open Access | Times Cited: 7

In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants
Calvin R. Wei, Zarrin Basharat, Godwin C. Lang’at
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 54-69
Open Access | Times Cited: 1

Novel Natural Inhibitors for Glioblastoma by Targeting Epidermal Growth Factor Receptor and Phosphoinositide 3-kinase
Atta Ullah, Saeed Ullah, Muhammad Waqas, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 40, pp. 6596-6613
Closed Access | Times Cited: 1

In silico study of potential SARS-CoV-2 antagonist from Clitoria ternatea.
Chian Ying Chun, Sabrina Xin Yi Khor, Adeline Yoke Yin Chia, et al.
PubMed (2023) Vol. 17, Iss. 3, pp. 3-10
Closed Access | Times Cited: 3

Nanotechnology meets immunology towards a rapid diagnosis solution: the COVID-19 outbreak challenge
Santos B. S. A. S., João Luís Reis-Cunha, Isadora C. Carvalho, et al.
RSC Advances (2022) Vol. 12, Iss. 49, pp. 31711-31728
Open Access | Times Cited: 5

Prioritization of bioactive compounds envisaging yohimbine as a multi targeted anticancer agent: insight from molecular docking and molecular dynamics simulation
Nasimudeen R. Jabir, Md Tabish Rehman, Mohamed F. Alajmi, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 20, pp. 10463-10477
Closed Access | Times Cited: 4

Drug Potency Prediction of SARS-CoV-2 Main Protease Inhibitors Based on a Graph Generative Model
Sarah Fadlallah, Carme Julià, Santiago Garcı́a-Vallvé, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8779-8779
Open Access | Times Cited: 1

Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches
Hee-Jung Lee, Hanul Choi, Aleksandra Nowakowska, et al.
The Journal of Microbiology (2023) Vol. 61, Iss. 7, pp. 703-711
Closed Access | Times Cited: 1

Physicochemical modeling and characterization of the adsorption mechanism of seven pharmaceutical molecules onto SARS-CoV-2 virus
Oumaima Kouira, S. Bayoudh, Houda Smati, et al.
Materials Chemistry and Physics (2023) Vol. 307, pp. 128219-128219
Closed Access | Times Cited: 1

Discovery of SARS-CoV-2 Antiviral Drugs Through Large-Scale Virtual Screening of FDA-Approved Drugs
Wahiba Ezzemani, Ahd Ouladlahsen, Haya Altawalah, et al.
Livestock diseases and management (2024), pp. 307-326
Closed Access

Enhanced targeting efficacy of baicalein analogues on the dimeric state of SARS-CoV-2 3CL protease compared to monomeric state
Ahmed I. Foudah, Aftab Alam
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access

Mutational insights among the structural proteins of SARS-CoV-2: frequencies and evolutionary trends in American countries
Mohammad Abavisani, Karim Rahimian, Reza Khayami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access

Mutational insights among the structural proteins of SARS-CoV-2; comprehensive analyses in the six continents
Mohammad Abavisani, Karim Rahimian, Bahar Mahdavi, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top